CoChat

Ciliary IFT80 balances canonical versus non-canonical hedgehog signalling for osteoblast differentiation

Open access
Yuan, Xue, Cao, Jay, He, Xiaoning, Serra, Rosa, Qu, Jun, Cao, Xu, Yang, Shuying · 2016 · Nature Communications

The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.

Abstract

Intraflagellar transport proteins (IFT) are required for hedgehog (Hh) signalling transduction that is essential for bone development, however, how IFT proteins regulate Hh signalling in osteoblasts (OBs) remains unclear. Here we show that deletion of ciliary IFT80 in OB precursor cells (OPC) in mice results in growth retardation and markedly decreased bone mass with impaired OB differentiation. Loss of IFT80 blocks canonical Hh–Gli signalling via disrupting Smo ciliary localization, but elevates non-canonical Hh–Gαi–RhoA–stress fibre signalling by increasing Smo and Gαi binding. Inhibition of RhoA and ROCK activity partially restores osteogenic differentiation of IFT80 -deficient OPCs by inhibiting non-canonical Hh–RhoA–Cofilin/MLC2 signalling. Cytochalasin D, an actin destabilizer, dramatically restores OB differentiation of IFT80 -deficient OPCs by disrupting actin stress fibres and promoting cilia formation and Hh–Gli signalling. These findings reveal that IFT80 is required for OB differentiation by balancing between canonical Hh–Gli and non-canonical Hh–Gαi–RhoA pathways and highlight IFT80 as a therapeutic target for craniofacial and skeletal abnormalities.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms11024

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Deletion of IFT80 causes a significant growth retardation and osteopenia. (a) Micro-CT of the femurs from 1-month-old OSX; IFT80+/+ mice and OSX;IFT80f/f mice. Yellow arrows indicate the bone defects. (b) Quantitative analysis of the percentage of bone volume to total bone volume (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), and trabecular spacing (Tb.Sp) in the femurs of 1-month-old OSX; IFT80+/+ mice and OSX;IFT80f/f mice (n=4 mice per group). (c) Histological H&E staining analysis of newborn mice tibia. Right panel shows higher magnification of trabecular bone area. Scale bars, 500 μm (left, black) or 100 μm (right, green) (d) Histological H&E staining analysis of 1-month mice tibia. Lower panel shows higher magnification of trabecular bone area. Scale bars, 500 μm (top, black) or 100 μm (bottom, blue) (e) Quantitative analysis of the percentage of bone area to total bone marrow space in tibia (black rectangle) of OSX; IFT80+/+ mice and OSX;IFT80f/f mice shown in c,d (n=4 mice per group). (f) Von Kossa staining of newborn mice tibia. Scale bars, 500 μm (left, black) or 200 μm (right, red). (g) Quantification of mineral apposition rate per bone surface (MAR/BS), bone formation rate (BFR), OB number per bone perimeter (Ob.N/B.Pm) and osteoclast number per bone perimeter (Oc.N/B.Pm) from double calcein injection experiment (n=3 mice per group). Error bars, s.e.m.; *P<0.05, **P<0.01 and ***P<0.0001 as determined by Student's t-test. NS, not statistically significant.
Figure 1 Deletion of IFT80 causes a significant growth retardation and osteopenia. (a) Micro-CT of the femurs from 1-month-old OSX; IFT80+/+ mice and OSX;IFT80f/f mice. Yellow arrows indicate the bone defects. (b) Quantitative analysis of the percentage of bone volume to total bone volume (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), and trabecular spacing (Tb.Sp) in the femurs of 1-month-old OSX; IFT80+/+ mice and OSX;IFT80f/f mice (n=4 mice per group). (c) Histological H&E staining analysis of newborn mice tibia. Right panel shows higher magnification of trabecular bone area. Scale bars, 500 μm (left, black) or 100 μm (right, green) (d) Histological H&E staining analysis of 1-month mice tibia. Lower panel shows higher magnification of trabecular bone area. Scale bars, 500 μm (top, black) or 100 μm (bottom, blue) (e) Quantitative analysis of the percentage of bone area to total bone marrow space in tibia (black rectangle) of OSX; IFT80+/+ mice and OSX;IFT80f/f mice shown in c,d (n=4 mice per group). (f) Von Kossa staining of newborn mice tibia. Scale bars, 500 μm (left, black) or 200 μm (right, red). (g) Quantification of mineral apposition rate per bone surface (MAR/BS), bone formation rate (BFR), OB number per bone perimeter (Ob.N/B.Pm) and osteoclast number per bone perimeter (Oc.N/B.Pm) from double calcein injection experiment (n=3 mice per group). Error bars, s.e.m.; *P<0.05, **P<0.01 and ***P<0.0001 as determined by Student's t-test. NS, not statistically significant.CC BY · PubMed Central
Figure 2 Deletion of IFT80 impairs OB differentiation. (a) ALP activity of wild-type OPCs treated with Ad–GFP or Ad-Cre at D7 of osteogenic induction (n=3, triplicates per group). (b) Alizarin Red staining of wild-type OPCs treated with Ad–GFP or Ad-Cre at D21 of osteogenic induction (n=3, triplicates per group). (c) QPCR analysis of IFT80 expression in IFT80f/f and IFT80d/d OPCs. The expression of IFT80 is normalized to GAPDH expression (n=4, triplicates per group). (d) Western blot analysis of IFT80 expression in IFT80f/f and IFT80d/d OPCs. IFT80 protein level is normalized to GAPDH (n=3). (e) ALP activity of IFT80f/f and IFT80d/d OPCs during osteogenesis at indicated time points (n=4, triplicates per group). (f) Alizarin Red staining of IFT80f/f and IFT80d/d OPCs induced with OS medium for 21 days (n=3, triplicates per group). (g) QPCR analysis for OB marker genes Runx2, osterix and osteocalcin in OS culture medium at day 0, day 3 and day 7 in IFT80f/f and IFT80d/d groups (n=4, triplicates per group). (h) Western blot analysis of p-Smads 1/5/8 expression in IFT80f/f and IFT80d/d OPCs. p-Smads 1/5/8 protein level was normalized to Smads 1/5/8 (n=3 wells per group). Data were analysed using an appropriate Student's t-test, one-way ANOVA, or two-way analysis of variance followed by post hoc Tukey's analysis. Error bars, s.e.m.; *P<0.05, **P<0.01, ***P<0.0001. NS, not statistically significant.
Figure 2 Deletion of IFT80 impairs OB differentiation. (a) ALP activity of wild-type OPCs treated with Ad–GFP or Ad-Cre at D7 of osteogenic induction (n=3, triplicates per group). (b) Alizarin Red staining of wild-type OPCs treated with Ad–GFP or Ad-Cre at D21 of osteogenic induction (n=3, triplicates per group). (c) QPCR analysis of IFT80 expression in IFT80f/f and IFT80d/d OPCs. The expression of IFT80 is normalized to GAPDH expression (n=4, triplicates per group). (d) Western blot analysis of IFT80 expression in IFT80f/f and IFT80d/d OPCs. IFT80 protein level is normalized to GAPDH (n=3). (e) ALP activity of IFT80f/f and IFT80d/d OPCs during osteogenesis at indicated time points (n=4, triplicates per group). (f) Alizarin Red staining of IFT80f/f and IFT80d/d OPCs induced with OS medium for 21 days (n=3, triplicates per group). (g) QPCR analysis for OB marker genes Runx2, osterix and osteocalcin in OS culture medium at day 0, day 3 and day 7 in IFT80f/f and IFT80d/d groups (n=4, triplicates per group). (h) Western blot analysis of p-Smads 1/5/8 expression in IFT80f/f and IFT80d/d OPCs. p-Smads 1/5/8 protein level was normalized to Smads 1/5/8 (n=3 wells per group). Data were analysed using an appropriate Student's t-test, one-way ANOVA, or two-way analysis of variance followed by post hoc Tukey's analysis. Error bars, s.e.m.; *P<0.05, **P<0.01, ***P<0.0001. NS, not statistically significant.CC BY · PubMed Central
Figure 3 Deletion of IFT80 disrupts cilia formation and inhibits canonical Hh–Gli signalling transduction in OPCs. (a) Immunofluorescence analysis of IFT80 in IFT80f/f and IFT80d/d OPCs. IFT80 (red) was co-stained with acetylated tubulin (ciliary axoneme, cyan). DAPI (nuclear marker) staining is used as counterstaining. Scale bars, 10 μm. (b) Immunofluorescence analysis of primary cilia in IFT80f/f and IFT80d/d OPCs. Primary cilia were stained with γ-tubulin (basal body, red) and acetylated α-tubulin (axoneme, cyan) antibody. The inset shows a high-power image of the basal body and axoneme. DAPI staining is used as counterstaining. Scale bars, 10 μm. (c) ALP activity of IFT80f/f and IFT80d/d OPCs at day 7 of OS induction with or without Shh stimulation (n=4, triplicates per group). (d) Alizarin Red of IFT80f/f and IFT80d/d OPCs at day 14 of OS induction with or without Shh stimulation (n=3, triplicates per group). (e) QPCR results showing Ptch1 and Gli1 expression in IFT80f/f and IFT80d/d OPCs with or without Shh stimulation (n=4, triplicates per group). (f) Reporter assay showing 8 × Gli responsive luciferase (p8 × Gli-Luc) activity in IFT80f/f and IFT80d/d OPCs with or without Shh stimulation (n=3, triplicates per group). (g) QPCR results showing BMP2 and Runx2 expression in IFT80f/f and IFT80d/d OPCs with or without Shh stimulation (n=4, triplicates per group). (h) ALP activity of IFT80f/f and IFT80d/d OPCs transfected with BMP2 or RUNX2 adenovirus. Both cells were induced for osteogenesis for 7 days (n=4, triplicates per group). (i) Alizarin Red staining at day 14 in OS culture. IFT80f/f and IFT80d/d OPCs were transfected with BMP2 or Runx2 adenovirus (n=4, triplicates per group). (j) QPCR result showing osterix and osteocalcin expression with BMP2 or Runx2 adenovirus transfection in IFT80f/f and IFT80d/d group (n=4, triplicates per group). Data points indicate the means, while error bars represent s.e.m. Data were analysed using two-way ANOVA followed by Tukey's multiple comparison test. *P<0.05, **P<0.01, ***P<0.0001. NS, not statistically significant.
Figure 3 Deletion of IFT80 disrupts cilia formation and inhibits canonical Hh–Gli signalling transduction in OPCs. (a) Immunofluorescence analysis of IFT80 in IFT80f/f and IFT80d/d OPCs. IFT80 (red) was co-stained with acetylated tubulin (ciliary axoneme, cyan). DAPI (nuclear marker) staining is used as counterstaining. Scale bars, 10 μm. (b) Immunofluorescence analysis of primary cilia in IFT80f/f and IFT80d/d OPCs. Primary cilia were stained with γ-tubulin (basal body, red) and acetylated α-tubulin (axoneme, cyan) antibody. The inset shows a high-power image of the basal body and axoneme. DAPI staining is used as counterstaining. Scale bars, 10 μm. (c) ALP activity of IFT80f/f and IFT80d/d OPCs at day 7 of OS induction with or without Shh stimulation (n=4, triplicates per group). (d) Alizarin Red of IFT80f/f and IFT80d/d OPCs at day 14 of OS induction with or without Shh stimulation (n=3, triplicates per group). (e) QPCR results showing Ptch1 and Gli1 expression in IFT80f/f and IFT80d/d OPCs with or without Shh stimulation (n=4, triplicates per group). (f) Reporter assay showing 8 × Gli responsive luciferase (p8 × Gli-Luc) activity in IFT80f/f and IFT80d/d OPCs with or without Shh stimulation (n=3, triplicates per group). (g) QPCR results showing BMP2 and Runx2 expression in IFT80f/f and IFT80d/d OPCs with or without Shh stimulation (n=4, triplicates per group). (h) ALP activity of IFT80f/f and IFT80d/d OPCs transfected with BMP2 or RUNX2 adenovirus. Both cells were induced for osteogenesis for 7 days (n=4, triplicates per group). (i) Alizarin Red staining at day 14 in OS culture. IFT80f/f and IFT80d/d OPCs were transfected with BMP2 or Runx2 adenovirus (n=4, triplicates per group). (j) QPCR result showing osterix and osteocalcin expression with BMP2 or Runx2 adenovirus transfection in IFT80f/f and IFT80d/d group (n=4, triplicates per group). Data points indicate the means, while error bars represent s.e.m. Data were analysed using two-way ANOVA followed by Tukey's multiple comparison test. *P<0.05, **P<0.01, ***P<0.0001. NS, not statistically significant.CC BY · PubMed Central
Figure 4 Deletion of IFT80 elevates non-canonical Hh–RhoA signalling transduction in OPCs. (a) IFT80f/f and IFT80d/d OBs were stained to visualize actin (red) and nucleus (blue). Scale bars, 100 μm. (b) Graph quantifying the percentage of stress fibres shown in a (n=3 with at least 15 cells analysed). (c) Activated RhoA was detected by ELISA-based G-LISA assay during osteogenesis at indicated time points (n=4, triplicates per group). (d) G-LISA assay showing RhoA activation in IFT80f/f and IFT80d/d OPCs treated with Shh for 20 min (n=4, triplicates per group). (e) G-LISA assay showing RhoA activation in IFT80f/f and IFT80d/d OPCs. Both OPCs were treated with Smo inhibitors SANT-1 and cyclopamine (CYC) and then stimulated with Shh for 20 min (n=4, triplicates per group). (f) G-LISA assay showing RhoA activation in IFT80f/f and IFT80d/d OPCs. Both OPCs were treated with PTX (Gαi inhibitor) or C3 (RhoA inhibitor) and then stimulated with Shh for 20min (n=4, triplicates per group). (g) Western blot analysis of phospho-MLC2 (p-MLC2) and phospho-Cofilin (p-Cofilin) in IFT80f/f and IFT80d/d OPCs. The levels of p-MLC2 and p-Cofilin are normalized to total MLC2 and Cofilin (n=3). Data points indicate the means, while error bars represent s.e.m. Data were analysed using two-way ANOVA followed by Tukey's multiple comparison test. *P<0.05, **P<0.01, ***P<0.0001.
Figure 4 Deletion of IFT80 elevates non-canonical Hh–RhoA signalling transduction in OPCs. (a) IFT80f/f and IFT80d/d OBs were stained to visualize actin (red) and nucleus (blue). Scale bars, 100 μm. (b) Graph quantifying the percentage of stress fibres shown in a (n=3 with at least 15 cells analysed). (c) Activated RhoA was detected by ELISA-based G-LISA assay during osteogenesis at indicated time points (n=4, triplicates per group). (d) G-LISA assay showing RhoA activation in IFT80f/f and IFT80d/d OPCs treated with Shh for 20 min (n=4, triplicates per group). (e) G-LISA assay showing RhoA activation in IFT80f/f and IFT80d/d OPCs. Both OPCs were treated with Smo inhibitors SANT-1 and cyclopamine (CYC) and then stimulated with Shh for 20 min (n=4, triplicates per group). (f) G-LISA assay showing RhoA activation in IFT80f/f and IFT80d/d OPCs. Both OPCs were treated with PTX (Gαi inhibitor) or C3 (RhoA inhibitor) and then stimulated with Shh for 20min (n=4, triplicates per group). (g) Western blot analysis of phospho-MLC2 (p-MLC2) and phospho-Cofilin (p-Cofilin) in IFT80f/f and IFT80d/d OPCs. The levels of p-MLC2 and p-Cofilin are normalized to total MLC2 and Cofilin (n=3). Data points indicate the means, while error bars represent s.e.m. Data were analysed using two-way ANOVA followed by Tukey's multiple comparison test. *P<0.05, **P<0.01, ***P<0.0001.CC BY · PubMed Central
Figure 5 Inhibition of non-canonical Hh signalling promotes osteogenesis. (a) ALP activity assay of IFT80f/f and IFT80d/d OPCs at day 7 of osteogenic induction. Both OPCs were treated with 0.5 μg ml−1 C3 (RhoA inhibitor) or 10 μM Y-27632 (ROCK inhibitor) (n=4, triplicates per group). (b) Western blot of GFP showing the expression level of GFP-tagged RhoA proteins in different groups. The bands of 27 kDa represent the GFP proteins in the IFT80f/f group that were transfected with Ad–GFP. The bands of 48 kDa represent the GFP-tagged RhoA. The levels of RhoAWT, RhoA19DN and RhoA63CA are normalized to GAPDH (n=3, NS, not statistically significant). (c) ALP activity assay of IFT80f/f and IFT80d/d OPCs transfected with RhoA19DN (dominant negative) and RhoA63CA (constitutively active) at day 7 in OS culture (n=3, triplicates per group). (d) Alizarin Red staining showing the OB mineralization of IFT80f/f and IFT80d/d OPCs at day 14 in OS culture with RhoA19DN and RhoA63CA transfection (n=3, triplicates per group). (e) QPCR shows Osterix and BMP2 expression at day 7 in OS culture in IFT80f/f and IFT80d/d OPCs, which were transfected with RhoA19DN and RhoA63CA (n=3, triplicates per group). (f) ALP activity assay of IFT80f/f and IFT80d/d OPCs at day 7 of OS induction with or without CytoD treatment (n=4, triplicates per group). (g) Alizarin Red staining showing the OB mineralization of IFT80f/f and IFT80d/d OPCs at day 14 in OS culture with or without CytoD treatment (n=4, triplicates per group). (h) QPCR shows BMP2, Runx2, osterix and osteocalcin expression in IFT80f/f and IFT80d/d OPCs with or without CytoD treatment. Data points indicate the means, while error bars represent s.e.m. Data were analysed using two-way ANOVA followed by Tukey's multiple comparison test. *P<0.05, **P<0.01, ***P<0.0001.
Figure 5 Inhibition of non-canonical Hh signalling promotes osteogenesis. (a) ALP activity assay of IFT80f/f and IFT80d/d OPCs at day 7 of osteogenic induction. Both OPCs were treated with 0.5 μg ml−1 C3 (RhoA inhibitor) or 10 μM Y-27632 (ROCK inhibitor) (n=4, triplicates per group). (b) Western blot of GFP showing the expression level of GFP-tagged RhoA proteins in different groups. The bands of 27 kDa represent the GFP proteins in the IFT80f/f group that were transfected with Ad–GFP. The bands of 48 kDa represent the GFP-tagged RhoA. The levels of RhoAWT, RhoA19DN and RhoA63CA are normalized to GAPDH (n=3, NS, not statistically significant). (c) ALP activity assay of IFT80f/f and IFT80d/d OPCs transfected with RhoA19DN (dominant negative) and RhoA63CA (constitutively active) at day 7 in OS culture (n=3, triplicates per group). (d) Alizarin Red staining showing the OB mineralization of IFT80f/f and IFT80d/d OPCs at day 14 in OS culture with RhoA19DN and RhoA63CA transfection (n=3, triplicates per group). (e) QPCR shows Osterix and BMP2 expression at day 7 in OS culture in IFT80f/f and IFT80d/d OPCs, which were transfected with RhoA19DN and RhoA63CA (n=3, triplicates per group). (f) ALP activity assay of IFT80f/f and IFT80d/d OPCs at day 7 of OS induction with or without CytoD treatment (n=4, triplicates per group). (g) Alizarin Red staining showing the OB mineralization of IFT80f/f and IFT80d/d OPCs at day 14 in OS culture with or without CytoD treatment (n=4, triplicates per group). (h) QPCR shows BMP2, Runx2, osterix and osteocalcin expression in IFT80f/f and IFT80d/d OPCs with or without CytoD treatment. Data points indicate the means, while error bars represent s.e.m. Data were analysed using two-way ANOVA followed by Tukey's multiple comparison test. *P<0.05, **P<0.01, ***P<0.0001.CC BY · PubMed Central
Figure 6 Inhibition of non-canonical Hh signalling reduces stress fibre density while promotes ciliogenesis. (a) IFT80f/f and IFT80d/d OPCs were stained for actin (red) and cilia (green) after C3 (RhoA inhibitor) or Y-27632 (ROCK inhibitor) treatment. DAPI staining is used as counterstaining. Scale bars, 25 μm. (b) Graph quantifying the percentage of stress fibres shown in a (n=3 with at least 15 cells analysed). (c) Calculated cilia length (n=10 cells) and cilia percentage (n=3 with at least 200 cells analysed) shown in a. (d) Western blot results showing ROCK1 and ROCK2 expression in IFT80f/f and IFT80d/d OPCs after transfected with control siRNA (siCTRL) or siRNA targeting ROCK1, siROCK2 or both. The level of ROCK1 and ROCK2 expression are normalized to GAPDH (n=3). (e) IFT80f/f and IFT80d/d OPCs were stained with stress fibre (red), cilia (green) and the nucleus (blue) after transfected with control siRNA (siCTRL) or siRNA targeting ROCK1, siROCK2 or both. Scale bars, 25 μm. (f) Calculated cilia length (n=10 cells) and cilia percentage (n=3 with at least 200 cells analysed) shown in e. (g) IFT80f/f and IFT80d/d OPCs were stained for actin (red) after CytoD treatment. DAPI staining is used as counterstaining. Scale bars, 100 μm. (h) Graph quantifying the number of stress fibres shown in g (n=3 with at least 15 cells analysed). (i) Immunofluorescence analysis of cilia (acetylated α-tubulin, red) in IFT80f/f and IFT80d/d OPCs with or without CytoD treatment. The insets show a high-power image of cilia. DAPI staining was used as counterstaining. Scale bars, 50 μm. (j) Calculated cilia length (n=3 with at least 10 cells measured) and ciliated cell percentage (n=3 with at least 200 cells analysed) shown in i. (k) QPCR showing Gli1 and Ptch1 expression in IFT80f/f and IFT80d/d OPCs with CytoD and Shh treatment (n=4, triplicates per group). Data points indicate the means, while error bars represent s.e.m. Data were analysed using two-way ANOVA followed by Tukey's multiple comparison test. *P<0.05, **P<0.01, ***P<0.0001. NS, not statistically significant.
Figure 6 Inhibition of non-canonical Hh signalling reduces stress fibre density while promotes ciliogenesis. (a) IFT80f/f and IFT80d/d OPCs were stained for actin (red) and cilia (green) after C3 (RhoA inhibitor) or Y-27632 (ROCK inhibitor) treatment. DAPI staining is used as counterstaining. Scale bars, 25 μm. (b) Graph quantifying the percentage of stress fibres shown in a (n=3 with at least 15 cells analysed). (c) Calculated cilia length (n=10 cells) and cilia percentage (n=3 with at least 200 cells analysed) shown in a. (d) Western blot results showing ROCK1 and ROCK2 expression in IFT80f/f and IFT80d/d OPCs after transfected with control siRNA (siCTRL) or siRNA targeting ROCK1, siROCK2 or both. The level of ROCK1 and ROCK2 expression are normalized to GAPDH (n=3). (e) IFT80f/f and IFT80d/d OPCs were stained with stress fibre (red), cilia (green) and the nucleus (blue) after transfected with control siRNA (siCTRL) or siRNA targeting ROCK1, siROCK2 or both. Scale bars, 25 μm. (f) Calculated cilia length (n=10 cells) and cilia percentage (n=3 with at least 200 cells analysed) shown in e. (g) IFT80f/f and IFT80d/d OPCs were stained for actin (red) after CytoD treatment. DAPI staining is used as counterstaining. Scale bars, 100 μm. (h) Graph quantifying the number of stress fibres shown in g (n=3 with at least 15 cells analysed). (i) Immunofluorescence analysis of cilia (acetylated α-tubulin, red) in IFT80f/f and IFT80d/d OPCs with or without CytoD treatment. The insets show a high-power image of cilia. DAPI staining was used as counterstaining. Scale bars, 50 μm. (j) Calculated cilia length (n=3 with at least 10 cells measured) and ciliated cell percentage (n=3 with at least 200 cells analysed) shown in i. (k) QPCR showing Gli1 and Ptch1 expression in IFT80f/f and IFT80d/d OPCs with CytoD and Shh treatment (n=4, triplicates per group). Data points indicate the means, while error bars represent s.e.m. Data were analysed using two-way ANOVA followed by Tukey's multiple comparison test. *P<0.05, **P<0.01, ***P<0.0001. NS, not statistically significant.CC BY · PubMed Central
Figure 7 Defects of Smo ciliary localization in IFT80d/d OPCs shifts the canonical Hh to non-canonical Hh transduction. (a) Immunostaining showing Smo localization (green) with Shh and purmorphomine (Pur) stimulation. Primary cilia were stained with acetylated α-tubulin antibody (red). DAPI staining is used as counterstaining. Scale bars, 15 μm (white) or 5 μm (yellow). (b) Quantification of GFP-positive cilia with or without Hh signalling activation shown in a (n=3 with at least 15 cells analysed). (c) QPCR results showing Ptch1 and Gli1 expression in both IFT80f/f and IFT80d/d OPCs with Shh or purmorphamine (Pur) stimulation (n=3, triplicates per group). (d) G-LISA assay showing that activated RhoA in IFT80f/f and IFT80d/d OPCs with Shh or purmorphamine (Pur) stimulation (n=4, triplicates per group). (e) Western blot showing the Gαi and Smo binding. IFT80f/f and IFT80d/d OPCs were treated with purmorphamine (Pur) for 10 min or 4 h, and cell lysates were used for immunoprecipitation and immunoblot with indicated antibodies. Smo binding was normalized to Smo levels in total lysates (n=3). Data points indicate the means, while error bars represent s.e.m. Data were analysed using two-way ANOVA followed by Tukey's multiple comparison test. *P<0.05, **P<0.01, ***P<0.0001. (f) Schematic representation of the proposed function of IFT80/cilia in canonical and non-canonical Hh signalling.
Figure 7 Defects of Smo ciliary localization in IFT80d/d OPCs shifts the canonical Hh to non-canonical Hh transduction. (a) Immunostaining showing Smo localization (green) with Shh and purmorphomine (Pur) stimulation. Primary cilia were stained with acetylated α-tubulin antibody (red). DAPI staining is used as counterstaining. Scale bars, 15 μm (white) or 5 μm (yellow). (b) Quantification of GFP-positive cilia with or without Hh signalling activation shown in a (n=3 with at least 15 cells analysed). (c) QPCR results showing Ptch1 and Gli1 expression in both IFT80f/f and IFT80d/d OPCs with Shh or purmorphamine (Pur) stimulation (n=3, triplicates per group). (d) G-LISA assay showing that activated RhoA in IFT80f/f and IFT80d/d OPCs with Shh or purmorphamine (Pur) stimulation (n=4, triplicates per group). (e) Western blot showing the Gαi and Smo binding. IFT80f/f and IFT80d/d OPCs were treated with purmorphamine (Pur) for 10 min or 4 h, and cell lysates were used for immunoprecipitation and immunoblot with indicated antibodies. Smo binding was normalized to Smo levels in total lysates (n=3). Data points indicate the means, while error bars represent s.e.m. Data were analysed using two-way ANOVA followed by Tukey's multiple comparison test. *P<0.05, **P<0.01, ***P<0.0001. (f) Schematic representation of the proposed function of IFT80/cilia in canonical and non-canonical Hh signalling.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 71 references

Cited by

Items 101–122 of 122

Metadata

Authors
Yuan, X., Cao, J., He, X., Serra, R., Qu, J., Cao, X., & Yang, S.
Affiliations
  • University at Buffalo, State University of New York (US)
  • Grand Forks Human Nutrition Research Center (US)
  • University of Alabama at Birmingham (US)
  • Johns Hopkins University (US)
Corresponding author
Yang, Shuying
Venue
Nature Communications
Published
2016-03-21
Volume
7
Issue
1
Pages
11024-11024
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2311799170
Cited by
122
References
71
Citations by year
2026: 7 · 2025: 7 · 2024: 4 · 2023: 9 · 2022: 20 · 2021: 21 · 2020: 12 · 2019: 15 · 2018: 12 · 2017: 12 · 2016: 3
FWCI
7.27
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health
  • National Institute on Aging (R01AG048388, AG048388)
  • National Cancer Institute (P30CA016056)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R03AR061052, AR066101, R01AR066101)
  • National Institute of Dental and Craniofacial Research (AR066101, R01DE023105, DE023105)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Keywords
intraflagellar transport, Hedgehog signaling, osteogenic differentiation, osteoblast precursors, RhoA, Gαi, stress fibers, ciliogenesis, bone mass, craniofacial anomalies, bone formation
MeSH terms
Animals, Bone Diseases, Metabolic, Carrier Proteins, Cell Differentiation, Cilia, Osteoblasts, Osteogenesis, Stem Cells, Signal Transduction, Gene Deletion, Mice, Knockout, rhoA GTP-Binding Protein, Stress Fibers, Organogenesis, Hedgehog Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.